Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-06-06
2006-06-06
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S560000, C426S541000, C426S601000, C426S607000, C426S610000
Reexamination Certificate
active
07056949
ABSTRACT:
An oil/fat composition comprising 5 to 99.9 wt. % of a monoglyccride having, as fatty acid constituents thereof, 15 to 90 wt % of an ω 3-unsaturated fatty acid having less than 20 carbon atoms, 1 to 80 wt. % of an ω 9-unsaturated fatty acid and 2 to 50 wt. % of an ω 9-unsaturated fatty acid; and 0.1 to 49.9 wt. % of a diglyceride, wherein a weight ratio of the diglyceride to the monoglyceride is less than 1 and the content of a polyunsaturated fatty acid having at least 4 carbon-to-carbon double bonds is 20% or less in all the fatty acid constituents. The oil/fat composition according to the present invention has excellent processing properties, good taste and excellent lowering action against glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) levels in blood. It is useful not only for pharmaceuticals but also for preventive or remedial foods of feeds effective for hepatic function disturbances or obesity.
REFERENCES:
patent: 5234699 (1993-08-01), Yeo
patent: 5288619 (1994-02-01), Brown et al.
patent: 5308832 (1994-05-01), Garleb et al.
patent: 5935828 (1999-08-01), Zaks et al.
patent: 6063762 (2000-05-01), Hong et al.
patent: 6448292 (2002-09-01), Koike et al.
patent: 6495536 (2002-12-01), Masui et al.
patent: 2002/0002154 (2002-01-01), Guivarc'h et al.
patent: 0 300 844 (1989-01-01), None
patent: 0 948 902 (1999-10-01), None
The Merck Index, 11thEdition, published 1989 by Merck & Co., Inc., p. 867, cit. 5383.
M.F. McCarty: “Interleukin-6 as a central mediator of cardiovascular risk associsted with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ehtanol and pentoxifylline” Database Biosis 'Online! Biosciences Information Service, May 1999 Database accession No. PREV199900353595.
Toshiyuki Shibata et al.: “Unsaturated fatty acid feeding prevents the development of acute hepatitis in Long-Evans cinnamon (LEC) rats” Database Biosis 'Online! Biosciences Information Service, Nov. 1999 Database accession No. PREV200000139637.
Hase Tadashi
Koike Shin
Murase Takatoshi
Yasumasu Takeshi
Henley III Raymond J.
Kao Corporation
LandOfFree
Oil/fat composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oil/fat composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oil/fat composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3650369